(Q47262610)

English

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.

scientific article published on 14 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Mehul Dalal

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jay Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Gregory C Connolly

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

0 references

publication date

14 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

648-655

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Epidemiology and pathophysiology of cancer-associated thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

The link between cancer and venous thromboembolism: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing risk of venous thromboembolism in the patient with cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer and the prothrombotic state

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

The prothrombotic state in cancer: pathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of clotting factors in cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Deep vein thrombosis in cancer: the scale of the problem and approaches to management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of venous thromboembolism in patients hospitalized with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboembolism in hospitalized neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of cancer-related venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombotic events in patients with cancer receiving antiangiogenesis agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost of atrial fibrillation in United States managed care organizations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemostatic complications of angiogenesis inhibitors in cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of a predictive model for chemotherapy-associated thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Controversial role of bevacizumab in the development of venous thromboembolic events

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27772

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27772

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22893596%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47262610&oldid=1424923397"